Cargando…

Evaluation of Support, a self-guided online type 1 diabetes self-management education and support web application—a mixed methods study

BACKGROUND: Type 1 diabetes requires making numerous daily decisions to maintain normoglycemia. Support is an evidence-based self-guided web application for type 1 diabetes diabetes self-management. OBJECTIVE: Evaluate users’ satisfaction with Support and investigate changes in self-reported frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Li Feng, Housni, Asmaa, Roy-Fleming, Amélie, Bandini, Aude, Delormier, Treena, Costa, Deborah Da, Brazeau, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540604/
https://www.ncbi.nlm.nih.gov/pubmed/37780064
http://dx.doi.org/10.1177/20552076231204435
Descripción
Sumario:BACKGROUND: Type 1 diabetes requires making numerous daily decisions to maintain normoglycemia. Support is an evidence-based self-guided web application for type 1 diabetes diabetes self-management. OBJECTIVE: Evaluate users’ satisfaction with Support and investigate changes in self-reported frequency of-, fear of- hypoglycemia, and diabetes-related self-efficacy. METHODS: Adults from a Quebec type 1 diabetes registry used Support. Data was collected through online surveys or extracted from the registry at 0, 6, and 12 months (number of episodes and fear of hypoglycemia). At 6 months, participants reported satisfaction with Support and diabetes-related self-efficacy. A sub-group of 16 users was interviewed about their experience. Transcripts were analyzed using inductive and deductive approaches. RESULTS: In total, 207 accounts were created (35% men, 96% White, mean age and diabetes duration: 49.3 ± 13.8 and 25.2 ± 14.7 years). At 6 months, the median [Q1; Q3] satisfaction was 40/49 [35; 45] with a mean decrease in hypoglycemia frequency of 0.43 episodes over 3 days (95% CI: −0.86; 0.00, p = 0.051) and of −1.98 score for fear (95% CI: −3.76; −0.20, p = 0.030). Half of the participants reported increased diabetes-related self-efficacy. CONCLUSIONS: Participants reported a high level of satisfaction with Support. Its use has the potential to facilitate hypoglycemia management and increase diabetes-related self-efficacy. TRIAL REGISTRATION: This study is registered on ClinicalTrials.gov NCT04233138.